Commentary Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.33696/cardiology.3.029

Should we Target Myostatin, PCSK9 or Their Combination in Ischemia or Reperfusion Injury?

  • 1Department of Surgical and Integrated Diagnostic Sciences, University of Genoa, Viale Benedetto XV 6, 16132 Genoa, Italy
  • 2Vascular and Endovascular Surgery Unit, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy
  • 3Research Center for Biologically Inspired Engineering in Vascular Medicine and Longevity, University of Genoa, Via Montallegro 1, 16145 Genoa, Italy
+ Affiliations - Affiliations

Corresponding Author

Chiara Barisione, chiara.barisione@unige.it

Received Date: April 08, 2022

Accepted Date: May 17, 2022

Author Information X